4//SEC Filing
Javitt Jonathan C 4
Accession 0001415889-25-024084
CIK 0001719406other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 3:36 PM ET
Size
5.7 KB
Accession
0001415889-25-024084
Insider Transaction Report
Form 4
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-04-09+125,000→ 125,000 totalExercise: $1.73Exp: 2035-04-09→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 1/3 of the Options shall vest on the first anniversary of the grant date, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to continued
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001303782
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 3:36 PM ET
- Size
- 5.7 KB